{"filing":{"accession_number":"0001104659-26-081588","cik":"0001434868","ticker":"ESPR","company_name":"Esperion Therapeutics, Inc.","form":"8-K","filing_date":"2026-07-08","report_date":null,"primary_document":"tm2620034d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1434868/000110465926081588/tm2620034d1_8k.htm"},"events":[{"id":16622,"run_id":14854,"accession_number":"0001104659-26-081588","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"This Item 5.07 discloses the results of a special stockholder meeting held on July 8, 2026, where shareholders voted to approve the Merger Agreement with Essence Parent Inc. and MergerCo. The filing reports voting results for the Merger Agreement Proposal (135.3M votes for, 22.8M against, 496K abstentions) and the Advisory Compensation Proposal (129.9M votes for, 22.3M against, 6.4M abstentions), which is the core disclosure required under Item 5.07 for shareholder vote results. This is material as it confirms stockholder approval of a transformative merger transaction.","company_name":"Esperion Therapeutics, Inc.","ticker":"ESPR","filing_date":"2026-07-08","form":"8-K","submitted_at":null,"items":[{"id":14778,"accession_number":"0001104659-26-081588","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This Item 5.07 discloses the results of a special stockholder meeting held on July 8, 2026, where shareholders voted to approve the Merger Agreement with Essence Parent Inc. and MergerCo. The filing reports voting results for the Merger Agreement Proposal (135.3M votes for, 22.8M against, 496K abstentions) and the Advisory Compensation Proposal (129.9M votes for, 22.3M against, 6.4M abstentions), which is the core disclosure required under Item 5.07 for shareholder vote results. This is material as it confirms stockholder approval of a transformative merger transaction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-08T12:33:38.630459+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":14778,"accession_number":"0001104659-26-081588","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This Item 5.07 discloses the results of a special stockholder meeting held on July 8, 2026, where shareholders voted to approve the Merger Agreement with Essence Parent Inc. and MergerCo. The filing reports voting results for the Merger Agreement Proposal (135.3M votes for, 22.8M against, 496K abstentions) and the Advisory Compensation Proposal (129.9M votes for, 22.3M against, 6.4M abstentions), which is the core disclosure required under Item 5.07 for shareholder vote results. This is material as it confirms stockholder approval of a transformative merger transaction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-08T12:33:38.630459+00:00","company_name":"Esperion Therapeutics, Inc.","ticker":"ESPR","filing_date":"2026-07-08"}]}